Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center - University of Texas Houston, Texas, United States
  • Aachen University Aachen, Germany
View Trial Details
Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

NCT01742988

Conditions
Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine Chicago, Illinois, United States
View Trial Details
Completed

Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+

NCT02128061

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • A. Z. Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Université Catholique de Louvain Saint Luc Brussels, Belgium
View all 97 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00278421

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum Augsburg Augsburg, Germany
  • Klinikum Bayreuth Bayreuth, Germany
  • Haematologisch-Onkologische Schwerpunktpraxis - Weilheim Berlin, Germany
View all 78 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004031

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Oregon Health & Science University Portland, Oregon, United States
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 15 locations
View Trial Details

Related conditions